PEAR News and Press, Pear Therapeutics Inc. From 03/21/23

2023-03-21 08:23:40 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Pear Therapeutics (NASDAQ: PEAR ) stock is climbing higher on Tuesday despite the company’s plans to explore strategic alternatives . That news was first announce...

2023-03-21 07:32:15 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips We’re starting off the day with a look at the biggest pre-market stock movers traders need to know about on Tuesday! Moving stocks this morning are earnings news, delisting talk, and...

2023-03-20 14:29:08 ET After losing over a third of the value in the previous session, Pear Therapeutics ( NASDAQ: PEAR ) shares continued to tumble on Monday as several Wall Street analysts downgraded the health tech company in reaction to its plans to explore strategic alter...

2023-03-17 09:43:17 ET Pear Therapeutics ( NASDAQ: PEAR ) is exploring strategic alternatives, which among things may include a sale of the company. The company has engaged MTS Health Partners as its exclusive financial advisor to assist in evaluating potential alternative...

Pear Therapeutics, Inc. (Nasdaq: PEAR) (“the Company”), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced that it is engaged in a process to explore strategic alternatives to maximize shareholder ...

2023-03-13 06:41:05 ET Summary Pear wasn't the fastest cash burner out there, but it was still burning a decent amount, and the SVB blowup is a huge setback to the VC funding environment. They have another 6 months before they need more capital. Huge reflexivity risk. At least...

Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced the Company will participate in the 43 rd Annual Cowen Healthcare Conference being held March 6-8, 2023 in Boston. C...

Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced the Company will participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference, which ...

Pear Therapeutics and BrightView Health have expanded a pilot program providing prescription digital therapeutics for substance use disorders. The expansion means that Pear's ( NASDAQ: PEAR ) reSET and reSET-O therapeutics are now available to BrightView patients in Kentucky,...

BrightView expands its initiative with reSET ® and reSET-O ® to patients across Kentucky, Ohio, Delaware, Massachusetts, and Virginia Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescrip...